New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)

Summary

The FDA's Adverse Event Monitoring System (AEMS) has identified potential signals of serious risks and new safety information. This is a general informational article about FDA safety monitoring processes without specific drug or company details.